# Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia

> **NCT04585607** · PHASE4 · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 47 (actual)

## Conditions studied

- Chronic Kidney Disease Requiring Chronic Dialysis

## Interventions

- **DEVICE:** A medium cut-off dialyzer (Theranova) will be used for HDx.
- **DEVICE:** A synthetic high-flux dialyzer (Polyflux)

## Key facts

- **NCT ID:** NCT04585607
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585607, "Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04585607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*